Percutaneous Cryoablation of Central Kidney Tumours With Temporary Renal Artery Occlusion

NCT05461027 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 16

Last updated 2024-12-27

No results posted yet for this study

Summary

Percutaneous cryoablation is an alternative to urological surgery for T1a tumours, whose oncological efficacy decreases for the most central tumours due to a cold sink effect.

Conditions

Sponsors & Collaborators

  • University Hospital, Strasbourg, France

    lead OTHER

Principal Investigators

  • Pierre-Alexis AUTRUSSEAU, MD · Service d'Imagerie Interventionnelle - CHU de Strasbourg - France

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-05-01
Primary Completion
2023-12-31
Completion
2023-12-31

Countries

  • France

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05461027 on ClinicalTrials.gov